Results
1 -
9 of
9
(Click
here to explore results)
- Cleavable linkers and their application in MS-based target identification. Hester A. Beard, Dimitris Korovesis, Suyuan Chen, Steven H. L. Verhelst
, Mol. Omics
, 2021
, 17
, 197
- Recent developments of small molecule γ-secretase modulators for Alzheimer's disease. Shekar Mekala, Grady Nelson, Yue-Ming Li
, RSC Med. Chem.
, 2020
, 11
, 1003
- Two decades of new drug discovery and development for Alzheimer's disease. Zhidong Liu, Aihua Zhang, Hui Sun, Ying Han, Ling Kong, Xijun Wang
, RSC Adv.
, 2017
, 7
, 6046
- Phenyl bioisosteres in medicinal chemistry: discovery of novel γ-secretase modulators as a potential treatment for Alzheimer's disease. H. Ratni, K. Baumann, P. Bellotti, X. A. Cook, L. G. Green, T. Luebbers, M. Reutlinger, A. F. Stepan, W. Vifian
, RSC Med. Chem.
, 2021
, 12
, 758
- Photocatalyzed radical multicomponent alkylacylation of [1.1.1]propellane to synthesize 1,3-disubstituted BCP ketones. Yong-Ze Liu, Yan Jiang, Jun-Lei Zhang, Yan Mei, Dong-Jie Li, Fei Pan
, Org. Chem. Front.
, 2023
, 10
, 4616
- Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates. Murugaiah A. M. Subbaiah, Jarkko Rautio, Nicholas A. Meanwell
, Chem. Soc. Rev.
, 2024
, 53
, 2099
- Anti-Aβ drug candidates in clinical trials and plasmonic nanoparticle-based drug-screen for Alzheimer's disease. Dongtak Lee, Gyudo Lee, Dae Sung Yoon
, Analyst
, 2018
, 143
, 2204
- The xanthate route to organofluorine derivatives. A brief account. Samir Z. Zard
, Org. Biomol. Chem.
, 2016
, 14
, 6891
- Current progress, challenges and future prospects of diagnostic and therapeutic interventions in Alzheimer's disease. K. Rajasekhar, Thimmaiah Govindaraju
, RSC Adv.
, 2018
, 8
, 23780